JOSÉ VICENTE
SINISTERRA GAGO
Investigador hasta 2011
GlaxoSmithKline (Spain)
Madrid, EspañaPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (6)
2006
-
Immobilised derivatives of Williopsis californica, Williopsis saturnus, Pachysolen tannophilus: New biocatalysts useful in the stereoselective oxidation of 1-tetralol
Enzyme and Microbial Technology, Vol. 39, Núm. 4, pp. 949-957
2004
-
Biotransformation of cyclohexanone using immobilized Geotrichum candidum NCYC49: Factors affecting the selectivity of the process
Journal of Molecular Catalysis B: Enzymatic, Vol. 28, Núm. 1, pp. 25-32
-
Diplogelasinospora grovesii IMI 171018, a new whole cell biocatalyst for the stereoselective reduction of ketones
Tetrahedron Asymmetry, Vol. 15, Núm. 6, pp. 951-962
-
High throughput screening and QSAR-3D/CoMFA: Useful tools to design predictive models of substrate specificity for biocatalysts
Molecules, Vol. 9, Núm. 8, pp. 673-693
-
Highly stereoselective reduction of haloketones using three new yeasts: Application to the synthesis of (S)-adrenergic β-blockers related to propranolol
Tetrahedron Asymmetry, Vol. 15, Núm. 5, pp. 763-770
-
Williopsis californica, Williopsis saturnus, and Pachysolen tannophilus: Novel microorganisms for stereoselective oxidation of secondary alcohols
Biotechnology and Bioengineering, Vol. 87, Núm. 5, pp. 632-640